Listed

Usana Health Sciences Inc

USNANYSECIK 896264HealthcareFiscal year ends Jan 3

Latest reported revenue, Q2 FY2026$223.3mRevenue, Q2 FY2026, three months to 2026-07-04$223.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figureThree months to Jul 4, 2026, from the 10-Q filed Aug 13, 2026.

Latest quarter: Q2 FY2026

Three months to Jul 4, 2026, against the same quarter a year earlier.

  • Revenue$223.3mRevenue, Q2 FY2026, three months to 2026-07-04$223.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure−5.3% on a year earlier
  • Gross margin78.3%Gross margin, Q2 FY2026, three months to 2026-07-04. gross profit / revenueGross profit: $174.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Revenue: $223.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure−0.4 pts on a year earlier
  • Operating margin−9.0%Operating margin, Q2 FY2026, three months to 2026-07-04. operating income / revenueOperating income: −$20.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Revenue: $223.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure−16.0 pts on a year earlier
  • Net margin−9.6%Net margin, Q2 FY2026, three months to 2026-07-04. net income / revenueNet income: −$21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Revenue: $223.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure−13.7 pts on a year earlier
  • Diluted EPS−$1.16Diluted EPS, Q2 FY2026, three months to 2026-07-04−$1.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figureSign changed from a year earlier
  • Free cash flow$20.2mFree cash flow, Q2 FY2026, three months to 2026-07-04. operating cash flow − capital expenditureOperating cash flow: $23.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure+180.4% on a year earlier

Last eight quarters

Full statements
Revenue$223.3mGross margin 78.3%
Diluted EPS−$1.16, Q2 FY2026
Free cash flow$20.2m, Q2 FY2026
Usana Health Sciences Inc, key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-28Q4 FY20242024-12-28Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27Q4 FY20252026-01-03Q1 FY20262026-04-04Q2 FY20262026-07-04Shape over the periods
Revenue$m200Revenue, Q3 FY2024, three months to 2024-09-28$200.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure214Revenue, Q4 FY2024, three months to 2024-12-28$213.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure250Revenue, Q1 FY2025, three months to 2025-03-29$249.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure236Revenue, Q2 FY2025, three months to 2025-06-28$235.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure214Revenue, Q3 FY2025, three months to 2025-09-27$213.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure226Revenue, Q4 FY2025, three months to 2026-01-03$226.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure250Revenue, Q1 FY2026, three months to 2026-04-04$250.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure223Revenue, Q2 FY2026, three months to 2026-07-04$223.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Gross margin%80.4%Gross margin, Q3 FY2024, three months to 2024-09-28. gross profit / revenueGross profit: $161.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Revenue: $200.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure82.0%Gross margin, Q4 FY2024, three months to 2024-12-28. gross profit / revenueGross profit: $175.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Revenue: $213.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure79.0%Gross margin, Q1 FY2025, three months to 2025-03-29. gross profit / revenueGross profit: $197.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Revenue: $249.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure78.7%Gross margin, Q2 FY2025, three months to 2025-06-28. gross profit / revenueGross profit: $185.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Revenue: $235.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure77.2%Gross margin, Q3 FY2025, three months to 2025-09-27. gross profit / revenueGross profit: $164.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Revenue: $213.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure78.2%Gross margin, Q4 FY2025, three months to 2026-01-03. gross profit / revenueGross profit: $176.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Revenue: $226.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure76.2%Gross margin, Q1 FY2026, three months to 2026-04-04. gross profit / revenueGross profit: $190.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Revenue: $250.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure78.3%Gross margin, Q2 FY2026, three months to 2026-07-04. gross profit / revenueGross profit: $174.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Revenue: $223.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Operating margin%7.8%Operating margin, Q3 FY2024, three months to 2024-09-28. operating income / revenueOperating income: $15.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Revenue: $200.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure3.8%Operating margin, Q4 FY2024, three months to 2024-12-28. operating income / revenueOperating income: $8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Revenue: $213.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure6.3%Operating margin, Q1 FY2025, three months to 2025-03-29. operating income / revenueOperating income: $15.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Revenue: $249.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure7.1%Operating margin, Q2 FY2025, three months to 2025-06-28. operating income / revenueOperating income: $16.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Revenue: $235.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure0.6%Operating margin, Q3 FY2025, three months to 2025-09-27. operating income / revenueOperating income: $1.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Revenue: $213.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure1.7%Operating margin, Q4 FY2025, three months to 2026-01-03. operating income / revenueOperating income: $3.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Revenue: $226.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure5.5%Operating margin, Q1 FY2026, three months to 2026-04-04. operating income / revenueOperating income: $13.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Revenue: $250.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure(9.0%)Operating margin, Q2 FY2026, three months to 2026-07-04. operating income / revenueOperating income: −$20.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Revenue: $223.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Net margin%5.3%Net margin, Q3 FY2024, three months to 2024-09-28. net income / revenueNet income: $10.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Revenue: $200.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure2.1%Net margin, Q4 FY2024, three months to 2024-12-28. net income / revenueNet income: $4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Revenue: $213.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure3.8%Net margin, Q1 FY2025, three months to 2025-03-29. net income / revenueNet income: $9.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Revenue: $249.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure4.1%Net margin, Q2 FY2025, three months to 2025-06-28. net income / revenueNet income: $9.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Revenue: $235.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure(3.1%)Net margin, Q3 FY2025, three months to 2025-09-27. net income / revenueNet income: −$6.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Revenue: $213.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figure(0.8%)Net margin, Q4 FY2025, three months to 2026-01-03. net income / revenueNet income: −$1.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Revenue: $226.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure3.0%Net margin, Q1 FY2026, three months to 2026-04-04. net income / revenueNet income: $7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Revenue: $250.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure(9.6%)Net margin, Q2 FY2026, three months to 2026-07-04. net income / revenueNet income: −$21.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Revenue: $223.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Diluted EPS$ per share0.56Diluted EPS, Q3 FY2024, three months to 2024-09-28$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figurenot reported (Diluted EPS not reported)0.49Diluted EPS, Q1 FY2025, three months to 2025-03-29$0.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure0.52Diluted EPS, Q2 FY2025, three months to 2025-06-28$0.52 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure(0.36)Diluted EPS, Q3 FY2025, three months to 2025-09-27−$0.36 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0000896264-25-000224.Report this figurenot reported (Diluted EPS not reported)0.41Diluted EPS, Q1 FY2026, three months to 2026-04-04$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure(1.16)Diluted EPS, Q2 FY2026, three months to 2026-07-04−$1.16 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0000896264-26-000056.Report this figure
Free cash flow$m27.1Free cash flow, Q3 FY2024, three months to 2024-09-28. operating cash flow − capital expenditureOperating cash flow: $29.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0000896264-25-000224. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0000896264-25-000224. Derived: 9-month figure less the 6-month figure.Report this figure4.0Free cash flow, Q4 FY2024, three months to 2024-12-28. operating cash flow − capital expenditureOperating cash flow: $5.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Capital expenditure: $1.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure12.7Free cash flow, Q1 FY2025, three months to 2025-03-29. operating cash flow − capital expenditureOperating cash flow: $15.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Capital expenditure: $2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure7.2Free cash flow, Q2 FY2025, three months to 2025-06-28. operating cash flow − capital expenditureOperating cash flow: $12.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Capital expenditure: $5.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure(5.2)Free cash flow, Q3 FY2025, three months to 2025-09-27. operating cash flow − capital expenditureOperating cash flow: −$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0000896264-25-000224. Derived: 9-month figure less the 6-month figure.Capital expenditure: $3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0000896264-25-000224. Derived: 9-month figure less the 6-month figure.Report this figure(6.2)Free cash flow, Q4 FY2025, three months to 2026-01-03. operating cash flow − capital expenditureOperating cash flow: −$3.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Capital expenditure: $2.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0000896264-26-000021. Derived: 12-month figure less the 9-month figure.Report this figure7.1Free cash flow, Q1 FY2026, three months to 2026-04-04. operating cash flow − capital expenditureOperating cash flow: $9.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-12, accession 0000896264-26-000034.Report this figure20.2Free cash flow, Q2 FY2026, three months to 2026-07-04. operating cash flow − capital expenditureOperating cash flow: $23.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Capital expenditure: $3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0000896264-26-000056. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$925.3mGross margin 78.3%
Diluted EPS$0.58, FY2025
Free cash flow$8.5m, FY2025
Usana Health Sciences Inc, key figures for the last five fiscal years
Line itemUnitFY20212022-01-01FY20222022-12-31FY20232023-12-30FY20242024-12-28FY20252026-01-03Shape over the periods
Revenue$m1,186Revenue, FY2021, twelve months to 2022-01-01$1.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000896264-24-000093.Report this figure999Revenue, FY2022, twelve months to 2022-12-31$998.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-12, accession 0000896264-25-000092.Report this figure921Revenue, FY2023, twelve months to 2023-12-30$921.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure855Revenue, FY2024, twelve months to 2024-12-28$854.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure925Revenue, FY2025, twelve months to 2026-01-03$925.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure
Gross margin%81.6%Gross margin, FY2021, twelve months to 2022-01-01. gross profit / revenueGross profit: $968.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-27, accession 0000896264-24-000093.Revenue: $1.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000896264-24-000093.Report this figure80.6%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $804.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-12, accession 0000896264-25-000092.Revenue: $998.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-12, accession 0000896264-25-000092.Report this figure80.8%Gross margin, FY2023, twelve months to 2023-12-30. gross profit / revenueGross profit: $744.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0000896264-26-000021.Revenue: $921.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure81.1%Gross margin, FY2024, twelve months to 2024-12-28. gross profit / revenueGross profit: $693.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0000896264-26-000021.Revenue: $854.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure78.3%Gross margin, FY2025, twelve months to 2026-01-03. gross profit / revenueGross profit: $724.4m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0000896264-26-000021.Revenue: $925.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure
Operating margin%14.3%Operating margin, FY2021, twelve months to 2022-01-01. operating income / revenueOperating income: $170.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-27, accession 0000896264-24-000093.Revenue: $1.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000896264-24-000093.Report this figure10.8%Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: $107.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-12, accession 0000896264-25-000092.Revenue: $998.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-12, accession 0000896264-25-000092.Report this figure10.1%Operating margin, FY2023, twelve months to 2023-12-30. operating income / revenueOperating income: $93.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021.Revenue: $921.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure7.8%Operating margin, FY2024, twelve months to 2024-12-28. operating income / revenueOperating income: $66.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021.Revenue: $854.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure4.0%Operating margin, FY2025, twelve months to 2026-01-03. operating income / revenueOperating income: $37.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021.Revenue: $925.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure
Net margin%9.8%Net margin, FY2021, twelve months to 2022-01-01. net income / revenueNet income: $116.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-27, accession 0000896264-24-000093.Revenue: $1.19bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-27, accession 0000896264-24-000093.Report this figure6.9%Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: $69.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-12, accession 0000896264-25-000092.Revenue: $998.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-12, accession 0000896264-25-000092.Report this figure6.9%Net margin, FY2023, twelve months to 2023-12-30. net income / revenueNet income: $63.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021.Revenue: $921.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure4.9%Net margin, FY2024, twelve months to 2024-12-28. net income / revenueNet income: $42.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021.Revenue: $854.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure1.2%Net margin, FY2025, twelve months to 2026-01-03. net income / revenueNet income: $10.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0000896264-26-000021.Revenue: $925.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure
Diluted EPS$ per share5.73Diluted EPS, FY2021, twelve months to 2022-01-01$5.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-27, accession 0000896264-24-000093.Report this figure3.59Diluted EPS, FY2022, twelve months to 2022-12-31$3.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-12, accession 0000896264-25-000092.Report this figure3.30Diluted EPS, FY2023, twelve months to 2023-12-30$3.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure2.19Diluted EPS, FY2024, twelve months to 2024-12-28$2.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure0.58Diluted EPS, FY2025, twelve months to 2026-01-03$0.58 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure
Free cash flow$m108Free cash flow, FY2021, twelve months to 2022-01-01. operating cash flow − capital expenditureOperating cash flow: $121.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-27, accession 0000896264-24-000093.Capital expenditure: $12.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-27, accession 0000896264-24-000093.Report this figure93.5Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $103.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-12, accession 0000896264-25-000092.Capital expenditure: $10.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-12, accession 0000896264-25-000092.Report this figure56.1Free cash flow, FY2023, twelve months to 2023-12-30. operating cash flow − capital expenditureOperating cash flow: $70.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0000896264-26-000021.Capital expenditure: $14.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure50.9Free cash flow, FY2024, twelve months to 2024-12-28. operating cash flow − capital expenditureOperating cash flow: $61.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0000896264-26-000021.Capital expenditure: $10.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure8.5Free cash flow, FY2025, twelve months to 2026-01-03. operating cash flow − capital expenditureOperating cash flow: $22.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0000896264-26-000021.Capital expenditure: $13.8m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0000896264-26-000021.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Usana Health Sciences Inc
FundQuarter endedReported valueSharesPut or callChange on the quarter before
BlackRock, Inc.2026-06-30$33.2m1,554,189Added+363,773
PZENA INVESTMENT MANAGEMENT LLC2026-06-30$25.7m1,205,587Added+96,654
RENAISSANCE TECHNOLOGIES LLC2026-06-30$20.5m958,520Reduced−59,110
DIMENSIONAL FUND ADVISORS LP2026-06-30$17.9m837,426Added+3,203
Nantahala Capital Management, LLC2026-06-30$17.3m810,074Unchanged
Nantahala Capital Management, LLC2026-06-30$17.3m810,074Unchanged
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$10.4m487,370Added+8,327
Creative Planning2026-06-30$8.9m417,971Added+224,823
AQR CAPITAL MANAGEMENT LLC2026-06-30$8.7m408,086Added+111,666
VANGUARD PORTFOLIO MANAGEMENT LLC2026-06-30$7.8m363,377Added+25,103

Recent filings

All 1,624 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Usana Health Sciences Inc, recent filings
FiledFormWhat it isAccession number
2026-10-0520:36 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits0000896264-26-000060
2026-08-1318:37 ET10-QQuarterly reportPeriod 2026-07-040000896264-26-000056
2026-08-0420:22 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000896264-26-000050
2026-05-2020:24 ET8-K5.07 Shareholder vote results0000896264-26-000036
2026-05-1220:35 ET10-QQuarterly reportPeriod 2026-04-040000896264-26-000034
2026-05-0520:17 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000896264-26-000030
2026-04-0720:50 ETDEF 14AProxy statementPeriod 2026-01-030000896264-26-000026
2026-03-3001:20 ETSCHEDULE 13D/AOwnership report, active investor, amended0001104659-26-037181
2026-03-1618:57 ET10-KAnnual reportPeriod 2026-01-030000896264-26-000021
2026-02-1801:33 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0000896264-26-000014

Latest annual report

Form 10-K for the fiscal year ended Jan 3, 2026Filed Mar 16, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
896264
Tickers
USNA
Exchange
NYSE
SIC code
2833 Medicinal Chemicals & Botanical Products
Sector
Healthcare
Fiscal year ends
Jan 3
Incorporated in
UT
Filer category
Accelerated filer
Former names
USANA INC (to 2000-04-27)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:27 ET. Listed shows no prices and gives no investment advice.